Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of enarodustat versus roxadustat for renal anemia in chronic kidney disease
ChiCTR2400082201Phase 4Recruiting
- Sponsor
- Shenzhen Second People's Hospital
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of enarodustat and roxadustat in anemia of renal disease and chronic kidney disease (CKD) (2 arms), sponsored by Shenzhen Second People's Hospital. Primary endpoint: Change in hemoglobin from baseline to weeks 7–9. Started Mar 2024; status: recruiting.
02
Drugs
enarodustatroxadustat
03
Conditions
anemia of renal diseasechronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR2400082201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082201.